Quarterly report pursuant to Section 13 or 15(d)

Operating Segments (Tables)

v3.23.1
Operating Segments (Tables)
3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information

The table below presents certain financial information of our operating segments for the three months ended March 31, 2023 and 2022 (in thousands):

 

    Treatment     Services     Segments Total     Corporate(1)     Consolidated Total  
Segment Reporting for the Quarter Ended March 31, 2023                  
    Treatment     Services     Segments Total     Corporate(1)     Consolidated Total  
Revenue from external customers   $ 9,594     $ 10,513     $ 20,107     $     $ 20,107  
Intercompany revenues     204       19       223              
Gross profit     1,252       1,757       3,009             3,009  
Research and development     67       3       70       29       99  
Interest income                       127       127  
Interest expense     (22 )     (1 )     (23 )     (30 )     (53 )
Interest expense-financing fees                       (20 )     (20 )
Depreciation and amortization     573       160       733       14       747  
Segment income (loss) before income taxes     157       943       1,100       (1,622 )     (522 )
Income tax benefit     (174 )     (30 )     (204 )           (204 )
Segment income (loss)     331       973       1,304       (1,622 )     (318 )
Expenditures for segment assets     748             748             748 (2)

 

    Treatment     Services     Segments Total     Corporate(1)     Consolidated Total  
Segment Reporting for the Quarter Ended March 31, 2022                  
    Treatment     Services     Segments Total     Corporate(1)     Consolidated Total  
Revenue from external customers   $ 7,479     $ 8,436     $ 15,915     $     $ 15,915  
Intercompany revenues                              
Gross profit     638       998       1,636             1,636  
Research and development     65       14       79       17       96  
Interest income                       11       11  
Interest expense     (14 )     (1 )     (15 )     (20 )     (35 )
Interest expense-financing fees                       (13 )     (13 )
Depreciation and amortization     371       71       442       14       456  
Segment (loss) income before income taxes     (481 )     285       (196 )     (1,726 )     (1,922 )
Income tax benefit     (559 )     (114 )     (673 )           (673 )
Segment income (loss)     78       399       477       (1,726 )     (1,249 )
Expenditures for segment assets     296       49       345             345 (2)

 

(1) Amounts reflect the activity for corporate headquarters not included in the segment information.

 

(2) Net of financed amount of $50,000 and $114,000 for the three months ended March 31, 2023 and 2022, respectively.